Christine A. Nash, SVP & Chief Commercial Officer at HYPERION THERAPEUTICS INC (HPTX), sold 5,000 shares at $24.36 ($124K) on 2015-01-20, disclosed to the SEC on 2015-01-22.
Scheduled sale ($124k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.36 | 2,500 | $61K | 49.1% |
| 2 | $25.27 | 2,500 | $63K | 50.9% |
| Total | $24.82 avg | 5,000 | $124K | 100% |
| Filing → |
| HPTX | SELL | 2015-03-10 | $293K | — | Filing → |
| HPTX | SELL | 2014-03-10 | $148K | — | Filing → |
| HPTX | SELL | 2014-01-14 | $241K | — | Filing → |